A new early-stage venture capital fund based in Göttingen, Lower Saxony, that aims to promote innovation in the regional bioscience ecosystem by providing funding and resources to promising startups and emerging companies.

Life Science Valley Wachstumsfonds

Welcome to the Life Science Valley Growth Fund, a new early-stage venture capital fund based in Göttingen, Lower Saxony. 

Our goal is to foster innovation in the regional life sciences ecosystem by providing funding and resources to promising startups and emerging companies.

Our fund actively seeks investment opportunities in a variety of
life sciences sectors, including biotechnology, medical technology, and digital health.

🌱 Exciting News: Our first portfolio company is Cultimate Foods!

We're thrilled to announce that CultiMate Foods, a dynamic biotech startup based in both Berlin's Biocube and at the Leibniz University in Hannover, received our first investment. 🎉 Their recent successful seed round closure, totaling 2.3 million, marks a significant milestone as they gear up to scale production processes and expand their commercial collaborations and operations.

We are more than happy to partner up with HTGF | High-Tech Gründerfonds, b.value AG, @Kale United, and Big Idea Ventures from New York 🤝. With this strong support, CultiMate Foods is poised to accelerate innovation and drive positive change in the food industry.

Join us in welcoming CultiMate Foods as they embark on this exciting journey of growth and impact! 🚀

#innovating #niedersachsen #LifeScience #Funding

Excited to announce that the Life Science Valley Wachstumsfonds will be joining the Heidelberger Life Science Investor Day tomorrow! 🌱💡

A big shoutout to the event organizers for bringing together this community of visionaries. Let's make the most of this chance to collaborate and drive progress in life sciences! 🔬💪 #LifeSciences #InvestorDay #Innovation #Biotechnology #Healthcare #Networking

Check it out: Germany announces close of €1bn fund of funds to invest in German and European VC

The majority of the new €1bn fund is expected to be invested into later-stage VCs that write bigger cheques, says Andreas Seehofer, investor relations manager at KfW Capital.

Other expectations of the fund include:
- Half of the fund will be invested in German VCs and half will be invested in European funds. 
- 75% of the fund will be invested into VCs that are Article 8 funds, promoting environmental and social governance (ESG), or Article 9 funds, that have sustainable investment or a reduction in carbon emissions as their objective. 
- digital services, life science, climate tech and food tech.

#vcfunding #entrepreneurship #lifesciences #laterstage

Metric
Company Name	Life Science Valley Wachstumsfonds
Symbol
MSH ID	DE:LSV-VENTURES
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	DE
Stage
Employee Count	4
Website	lsv-ventures.de
LinkedIn	lsv-ventures
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

LSV-

DE:LSV-VENTURES

Life Science Valley Wachstumsfonds

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue